ATM mutations and protein expression are not associated with familial B-CLL cases.

[1]  R. Houlston,et al.  ATM mutations are rare in familial chronic lymphocytic leukemia , 2002 .

[2]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.

[3]  G. Marti,et al.  Clinical Characteristics of Familial B-CLL in the National Cancer Institute Familial Registry , 2001, Leukemia & lymphoma.

[4]  H. Döhner,et al.  Mantle cell lymphoma is characterized by inactivation of the ATM gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Berrebi,et al.  Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia , 1999, Leukemia.

[6]  H. Döhner,et al.  Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. , 1999, Blood.

[7]  T. Stankovic,et al.  Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia , 1999, The Lancet.

[8]  H. Kantarjian,et al.  Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. , 1998, Cancer research.

[9]  M. Horwitz,et al.  The genetics of familial leukemia , 1997, Leukemia.

[10]  M. James,et al.  11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. , 1997, Blood.

[11]  C. Croce,et al.  ATM mutations in cancer families. , 1996, Cancer research.

[12]  A. Taylor,et al.  Leukemia and lymphoma in ataxia telangiectasia. , 1996, Blood.

[13]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[14]  M. Swift,et al.  Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. , 1986, Journal of the National Cancer Institute.

[15]  L. Bullinger,et al.  Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course , 2002, Leukemia.

[16]  F. Bosch,et al.  ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. , 2002, Blood.

[17]  T. Dörk,et al.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families. , 1999, Human molecular genetics.

[18]  J. D. Funkhouser,et al.  Cancer susceptibility in ataxia-telangiectasia. , 1992, Leukemia.